vaccine

Russia plans COVID-19 vaccine output at 6 million doses a month

Russia expects to produce between 1.5 million and 2 million doses per month of its potential COVID-19 vaccine by the year end, gradually ramping up production to 6 million doses…

Read More Here

UK’s Chief Medical Officer warns of no COVID-19 vaccine before winter of 2021

The Chief Medical Officer has warned the UK it is unlikely there will be a vaccine to deal with coronavirus before the winter of 2021. Chris Whitty has warned the…

Read More Here

China approves human testing for coronavirus vaccine cultivated within insect cells

China has approved human testing for a potential coronavirus vaccine cultivated within insect cells, local government in the southwestern city of Chengdu said on Saturday. China is in a global…

Read More Here

Peru, Morocco to test China Sinopharm’s COVID-19 vaccine in Phase 3 trial

Authorities in Peru and Morocco have approved Phase 3 clinical trials for a potential COVID-19 vaccine developed by China National Biotec Group (CNBG), the company said late on Thursday on…

Read More Here

Cuba to start clinical trials of potential coronavirus vaccine

Cuba kicks off clinical trials next week of a potential coronavirus vaccine called “Soberana 01” (“Sovereign 01”) developed by its state-run Finlay Institute, with results due in February, state-run media…

Read More Here

Mexico exploring phase 3 trials of Russian coronavirus vaccine

Mexico told Moscow it would like to carry out phase 3 testing of Russia’s coronavirus vaccine, as part of the Latin American country’s intensifying efforts to secure early supplies of…

Read More Here

Turkey in talks with Germany, China, Russia on vaccine trials

Turkey is in talks with Russia, Germany and China about conducting Phase 3 trials for coronavirus vaccines developed in those countries, Health Minister Fahrettin Koca said. Germany and China have…

Read More Here

A look at the WHO’s struggle for a global COVID-19 vaccine plan

The World Health Organization (WHO) on Tuesday urged countries to join a global pact aimed at ensuring less wealthy countries have access to COVID-19 vaccines, warning about the risks from…

Read More Here

Pope warns rich countries against coronavirus vaccine nationalism

Rich countries should not hoard a coronavirus vaccine and should only give pandemic-related bailouts to companies committed to protecting the environment, helping the most needy and the 'common good', Pope…

Read More Here

German institute says coronavirus vaccinations could start in early 2021

The head of Germany's vaccines regulator said some groups of people living in Germany could be vaccinated early next year against the coronavirus that has killed hundreds of thousands and…

Read More Here

Testing of CanSino’s COVID-19 candidate vaccine begins in Russia

A late-stage trial of a COVID-19 candidate vaccine from CanSino Biologics Inc has started in Russia, registration records showed, as the Chinese pharmaceutical firm steps up testing abroad to close…

Read More Here

Mexico president says COVID-19 vaccine expected to be ready early next year

Mexican President Andres Manuel Lopez Obrador expects to be able to put a COVID-19 vaccine into use in the country during the first quarter next year, he said in a…

Read More Here

Britain encourages at-risk groups to sign up for COVID-19 vaccine trials

Britain on Monday urged elderly people and volunteers from Black and Asian minority groups to sign up to a COVID-19 vaccine trial registry to boost efforts to find a working…

Read More Here

China grants country’s first COVID-19 vaccine patent to CanSino

China's vaccine specialist CanSino Biologics Inc has won a patent approval from Beijing for its COVID-19 vaccine candidate Ad5-nCOV, state media reported, citing documents from the country's intellectual property regulator.…

Read More Here

Russia starts production of COVID-19 vaccine

Russia has started manufacturing its new vaccine for COVID-19, the Interfax news agency reported on Saturday, citing the health ministry. Russia has said the vaccine, developed by Moscow's Gamaleya Institute…

Read More Here

European Commission reaches deal for purchase of 300 million doses of vaccine – UPDATE

The European Commission said on Friday it had reached a deal with British pharmaceutical firm AstraZeneca for the purchase of at least 300 million doses of its potential COVID-19 vaccine.…

Read More Here

Andrew Lloyd Webber volunteers for Oxford’s vaccine trial

Musicals composer Andrew Lloyd Webber has volunteered for a coronavirus vaccine trial. Lloyd Webber announced the move on Twitter on Wednesday and received high praise from those in the theater…

Read More Here

Argentina and Mexico to produce AstraZeneca COVID-19 vaccine

Argentina and Mexico will produce the AstraZeneca COVID-19 vaccine for most of Latin America, Argentine President Alberto Fernandez announced after a meeting with company executives involved in the project. An…

Read More Here

Germany optimistic on a vaccine in coming months and certainly next year

German Health Minister Jens Spahn on Thursday told ZDF television that he expected there would be a COVID-19 vaccine in the coming months and definitely next year. "I'm optimistic that…

Read More Here

Philippines eyes clinical trials for Russian COVID-19 vaccine in October

The Philippines plans to start clinical trials for a Russian coronavirus vaccine in October, with President Rodrigo Duterte expected to be inoculated as early as May 2021, the presidential spokesman…

Read More Here

Vir Biotech to begin mid-to-late stage study of COVID-19 drug candidate in August

Vir Biotechnology Inc said on Tuesday it plans to start a mid-to-late stage trial of its COVID-19 drug candidate in August, as drugmakers across the globe rush to find treatments…

Read More Here

Russia says allegations COVID-19 vaccine is unsafe are groundless

Russia said on Wednesday the first batch of its Covid-19 vaccine would be ready for some medics within two weeks and rejected as "groundless" safety concerns aired by some experts…

Read More Here

U.S. signs $1.5 billion deal with Moderna for 100 million doses of COVID-19 vaccine

The United States has entered an agreement with drugmaker Moderna Inc to acquire 100 million doses of its potential COVID-19 vaccine for around $1.5 billion, the company and White House…

Read More Here

Russia becomes first country to approve a COVID-19 vaccine, says Putin

President Vladimir Putin said on Tuesday that Russia had become the first country in the world to grant regulatory approval to a COVID-19 vaccine after less than two months of…

Read More Here

Speed of COVID-19 vaccine race raises safety concerns

The frenetic race to develop a COVID-19 vaccine has intensified safety concerns about an inoculation, prompting governments and drugmakers to raise awareness to ensure their efforts to beat the coronavirus…

Read More Here

Only half of Britons would accept being vaccinated against Covid-19

In Britain, only half the population definitely would accept being vaccinated against Covid-19. That is the shock conclusion of a group of scientists and pollsters who have found that only…

Read More Here

A look at AstraZeneca’s potential coronavirus vaccine

AstraZeneca signed its first COVID-19 vaccine supply deal with a Chinese company, Kangtai Bio, opening up distribution to one of the world's most populous countries. Drugmakers are racing to combat…

Read More Here

Swiss government signs agreement with Moderna for COVID-19 vaccine

Switzerland has signed an agreement with Moderna to secure early access to the COVID-19 vaccine the U.S. biotech company is developing, the government said on Friday. Switzerland will get 4.5…

Read More Here

Trump says coronavirus vaccine possible before Nov. 3

U.S. President Donald Trump said on Thursday it was possible the United States would have a coronavirus vaccine before the Nov. 3 election, a more optimistic forecast on timing than…

Read More Here

Canada signs deals with Pfizer, Moderna for experimental COVID-19 vaccine

Canada has signed separate deals with Pfizer Inc and Moderna Inc to supply millions of doses of their experimental coronavirus vaccines, a top official announced. Procurement Minister Anita Anand said…

Read More Here

Moderna prices COVID-19 vaccine at $32-$37 per dose for smaller volume deals

Moderna Inc announced smaller volume agreements for its experimental coronavirus vaccine have been priced in the range of $32 to $37 per dose, higher than the price set by the…

Read More Here

French group Eurofins launches new, lower-cost COVID-19 test

French diagnostics company Eurofins is launching a new, lower-cost product to detect the presence of SARS-CoV-2 virus responsible for the COVID-19 disease, the company said on Thursday. For the testing,…

Read More Here

Novavax coronavirus vaccine induces immune response in early study

Novavax Inc said its experimental COVID-19 vaccine produced high levels of antibodies against the novel coronavirus, according to initial data from a small, early-stage clinical trial. The company said it…

Read More Here

Zydus Cadila’s COVID-19 vaccine candidate found safe in early-stage human trial

India's Zydus Cadila said on Wednesday its COVID-19 vaccine candidate was found to be safe and well-tolerated in an early-stage human trial. The company will now start a mid-stage trial…

Read More Here

Next big COVID-19 treatment may be manufactured antibodies

As the world awaits a COVID-19 vaccine, the next big advance in battling the pandemic could come from a class of biotech therapies widely used against cancer and other disorders - antibodies designed specifically to attack this…

Read More Here

Rival drugmakers launch joint trial of medicines for COVID-19

Rival drugmakers AbbVie Inc, Amgen Inc and Takeda Pharmaceuticals Inc on Monday said they have begun treating patients in a trial to quickly show whether a drug from each company…

Read More Here

UK signs deal with Wockhardt to boost vaccine manufacturing process

Britain said on Monday it had partnered with Indian drugmaker Wockhardt to boost COVID-19 vaccine manufacturing and hopes the firms could start work as soon as next month. The agreement…

Read More Here

U.S. makes deal for 100 million doses of coronavirus vaccine, deaths expected to rise

Two major drug companies will supply the U.S. government with 100 million doses of an experimental coronavirus vaccine, the Trump administration announced, as the nation's top health agency predicted that…

Read More Here

Chinese-backed hackers targeted COVID-19 vaccine firm Moderna

Chinese government-linked hackers targeted biotech company Moderna Inc, a leading U.S.-based coronavirus vaccine research developer, earlier this year in a bid to steal valuable data, according to a U.S. security…

Read More Here

J&J starts human safety trial for its COVID-19 vaccine candidate

Johnson & Johnson on Thursday kicked off U.S. human safety trials for its COVID-19 vaccine after releasing details of a study in monkeys that showed its best-performing vaccine candidate offered…

Read More Here

“So far, so good” on leading COVID vaccine, says AstraZeneca

Britain's AstraZeneca said on Thursday that good data was coming in so far on its vaccine for COVID-19, already in large-scale human trials and widely seen as the front-runner in…

Read More Here

Moderna’s COVID-19 vaccine candidate moves into late-stage trial

Moderna Inc said on Monday it has started a U.S. government-backed late-stage trial evaluating its COVID-19 vaccine candidate, mRNA-1273, in about 30,000 adults who do not have the respiratory illness…

Read More Here

EU eyes COVID-19 vaccines at less than $40, shuns WHO-led alliance

The European Union is not interested in buying potential COVID-19 vaccines through an initiative co-led by the World Health Organisation as it deems it slow and high-cost, two EU sources told Reuters, noting…

Read More Here

China’s Sinopharm says coronavirus vaccine could be ready by year-end

A coronavirus vaccine candidate developed by China National Pharmaceutical Group (Sinopharm) could be ready for public use by the end of this year, state media reported on Wednesday, ahead of…

Read More Here

U.S. to pay Pfizer $1.95 bln to produce millions of doses of COVID-19 vaccine

Pfizer Inc and German biotech firm BioNTech SE will get $1.95 billion from the U.S. government to produce and deliver 100 million doses of their COVID-19 vaccine candidate. The agreement…

Read More Here

China’s Sinovac vaccine becomes third worldwide to enter Phase 3 clinical trial

Brazil on Tuesday approved clinical trials starting in August for a potential COVID-19 vaccine under joint development by U.S. pharmaceutical company Pfizer and Germany's BioNTech - the third such vaccine…

Read More Here

UK coronavirus vaccine prompts immune response

AstraZeneca’s experimental COVID-19 vaccine was safe and produced an immune response in early-stage clinical trials in healthy volunteers, data showed on Monday. The vaccine, called AZD1222 and under development by…

Read More Here

J&J says in talks with Japan, Gates Foundation to lock in deals on COVID-19 vaccine

Johnson & Johnson is in talks with the government of Japan and the Bill and Melinda Gates Foundation about locking up allocations of its potential COVID-19 vaccine in advance of…

Read More Here

India’s Cadila aims to complete trial of coronavirus vaccine by March

India's Zydus Cadila plans to complete late-stage trials for its novel coronavirus vaccine candidate by February or March and could produce up to 100 million doses a year initially if…

Read More Here

Russia expects to make COVID-19 vaccine being developed in Britain

Russia expects a deal with AstraZeneca for it to manufacture a COVID-19 vaccine being developed by the pharmaceuticals giant and Oxford University to go ahead despite allegations it has been…

Read More Here

Possible breakthrough in coronavirus vaccine development by Oxford University

Researchers at the University of Oxford believe they have made a breakthrough in the development of a coronavirus vaccine. Human trials are reported to have shown promising results after the…

Read More Here

European Parliament to allow COVID-19 vaccines to be developed more quickly

As part of the EU's efforts to hasten the availability of a vaccine against the novel corinavirus, the European Parliament has adoped a regulation allowing such vaccines and treatments be…

Read More Here

China’s CanSino in talks for COVID-19 vaccine Phase III trial overseas

Chinese vaccine developer CanSino Biologics is in talks with Russia, Brazil, Chile and Saudi Arabia to launch a Phase III trial of its experimental COVID-19 vaccine, its co-founder announced. China's…

Read More Here

UK has opted out of EU coronavirus vaccine programme

The UK government has rejected the chance to join the European Union’s coronavirus vaccine programme due to concerns over “costly delays”, according to sources. The EU is planning to spend…

Read More Here

Johnson & Johnson CEO warns potential COVID-19 vaccine not ‘single solution’ to pandemic

U.S. drugmaker Johnson & Johnson aims to begin clinical testing of its COVID-19 vaccine in the coming weeks and produce billions of doses in 2021, chief executive officer Alex…

Read More Here

BioNTech and Pfizer’s COVID-19 vaccine shows potential in human trial

A COVID-19 vaccine developed by German biotech firm BioNTech and U.S. pharmaceutical giant Pfizer has shown potential and was found to be well tolerated in early-stage human trials, the companies…

Read More Here

CanSino’s COVID-19 vaccine candidate approved for military use in China

China's military has received the greenlight to use a COVID-19 vaccine candidate developed by its research unit and CanSino Biologics after clinical trials proved it was safe and somewhat efficient,…

Read More Here